1. Home
  2. CSTL vs AHRT Comparison

CSTL vs AHRT Comparison

Compare CSTL & AHRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$21.16

Market Cap

611.1M

Sector

Health Care

ML Signal

HOLD

AHRT

AH Realty Trust Inc. Common Stock

N/A

Current Price

$6.80

Market Cap

501.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
CSTL
AHRT
Founded
2007
1979
Country
United States
United States
Employees
N/A
98
Industry
Medical Specialities
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
611.1M
501.3M
IPO Year
2019
2013

Fundamental Metrics

Financial Performance
Metric
CSTL
AHRT
Price
$21.16
$6.80
Analyst Decision
Strong Buy
Hold
Analyst Count
6
1
Target Price
$45.50
$7.00
AVG Volume (30 Days)
468.8K
901.1K
Earning Date
05-06-2026
05-04-2026
Dividend Yield
N/A
9.30%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$344,229,000.00
N/A
Revenue This Year
$2.42
$854.92
Revenue Next Year
$12.69
$11.36
P/E Ratio
N/A
N/A
Revenue Growth
3.66
N/A
52 Week Low
$14.59
$5.13
52 Week High
$44.28
$6.98

Technical Indicators

Market Signals
Indicator
CSTL
AHRT
Relative Strength Index (RSI) 47.27 68.05
Support Level $17.72 $5.93
Resistance Level $24.46 N/A
Average True Range (ATR) 1.12 0.17
MACD 0.37 0.01
Stochastic Oscillator 74.65 78.46

Price Performance

Historical Comparison
CSTL
AHRT

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

About AHRT AH Realty Trust Inc. Common Stock

AH Realty Trust Inc is a real estate investment trust (REIT). It owns, operates, and acquires high-quality properties across the Mid-Atlantic and Southeast, creating lasting value for investors, partners, clients, tenants, and communities. The group focuses on operating and acquiring high-quality, well-positioned assets with growth potential and delivering long-term value for shareholders. Its portfolio includes Harbor Point, Southern Post, The Interlock, and Others.

Share on Social Networks: